interactions:
- request:
    body: retmax=1000&db=pubmed&retmode=xml&api_key=<omitted>&id=10485824&id=6677511&id=2877511&id=6143560&id=3709451&id=3934796&id=8761421&id=10357793&id=20358181&id=6355494&id=8998951&id=3383337&id=12209194&id=11995694&id=12215663&id=1632818&id=3180084&id=14727734&id=23625783&id=11246142
    headers:
      Accept:
      - application/json
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      Content-Length:
      - '307'
      Content-Type:
      - application/x-www-form-urlencoded
      User-Agent:
      - hawc
    method: POST
    uri: https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi
  response:
    body:
      string: '<?xml version="1.0" ?>

        <!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January
        2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">

        <PubmedArticleSet>

        <PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">10485824</PMID><DateCompleted><Year>1999</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2017</Year><Month>02</Month><Day>14</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0192-6233</ISSN><JournalIssue
        CitedMedium="Print"><Volume>27</Volume><Issue>4</Issue><PubDate><Year>1999</Year><Season>Jul-Aug</Season></PubDate></JournalIssue><Title>Toxicologic
        pathology</Title><ISOAbbreviation>Toxicol Pathol</ISOAbbreviation></Journal><ArticleTitle>Quantitative
        analysis of the lobular distribution of S-phase in rat liver following dietary
        administration of di(2-ethylhexyl)phthalate.</ArticleTitle><Pagination><StartPage>436</StartPage><EndPage>440</EndPage><MedlinePgn>436-40</MedlinePgn></Pagination><Abstract><AbstractText>A
        simple image-analysis method is described, whereby the distribution of hepatocytes
        that have entered S-phase, as distinguished by the incorporation of bromodeoxyuridine,
        can be related to the position of the central and portal veins of the hepatic
        lobule. Hepatocyte S-phase was induced in the livers of male and female F344
        rats by administration of di(2-ethylhexyl)phthalate (DEHP) in the diet for
        7 days at 2 dose levels, and these livers were used to develop the procedure.
        The distributions of the S-phase between control and DEHP-treated livers were
        compared using statistical techniques. The results showed notable differences
        in the distribution of S-phase between male and female rats as well as limited
        dose-related effects.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Soames</LastName><ForeName>A R</ForeName><Initials>AR</Initials><AffiliationInfo><Affiliation>Zeneca
        Central Toxicology Laboratory, Alderley Park, Macclesfield, Cheshire, United
        Kingdom. Tony.Soames@ctl.zeneca.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cliffe</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Pate</LastName><ForeName>I</ForeName><Initials>I</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Pathol</MedlineTA><NlmUniqueID>7905907</NlmUniqueID><ISSNLinking>0192-6233</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>G34N38R2N1</RegistryNumber><NameOfSubstance
        UI="D001973">Bromodeoxyuridine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001973" MajorTopicYN="N">Bromodeoxyuridine</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003627" MajorTopicYN="N">Data Interpretation, Statistical</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004032" MajorTopicYN="Y">Diet</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000008" MajorTopicYN="Y">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002149" MajorTopicYN="N">Energy Intake</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000166"
        MajorTopicYN="N">cytology</QualifierName><QualifierName UI="Q000187" MajorTopicYN="Y">drug
        effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016196" MajorTopicYN="Y">S Phase</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D012737" MajorTopicYN="N">Sex Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>9</Month><Day>15</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>9</Month><Day>15</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10485824</ArticleId><ArticleId IdType="doi">10.1177/019262339902700407</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6677511</PMID><DateCompleted><Year>1984</Year><Month>08</Month><Day>01</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0165-2214</ISSN><JournalIssue
        CitedMedium="Print"><Volume>11</Volume><PubDate><Year>1983</Year></PubDate></JournalIssue><Title>Developments
        in toxicology and environmental science</Title><ISOAbbreviation>Dev Toxicol
        Environ Sci</ISOAbbreviation></Journal><ArticleTitle>Species differences in
        di-(2-ethylhexyl) phthalate-induced hepatic peroxisome proliferation.</ArticleTitle><Pagination><StartPage>595</StartPage><EndPage>598</EndPage><MedlinePgn>595-8</MedlinePgn></Pagination><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Lake</LastName><ForeName>B G</ForeName><Initials>BG</Initials></Author><Author
        ValidYN="Y"><LastName>Gray</LastName><ForeName>T J</ForeName><Initials>TJ</Initials></Author><Author
        ValidYN="Y"><LastName>Foster</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Stubberfield</LastName><ForeName>C R</ForeName><Initials>CR</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Dev
        Toxicol Environ Sci</MedlineTA><NlmUniqueID>7706742</NlmUniqueID><ISSNLinking>0165-2214</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008647" MajorTopicYN="N">Mesocricetus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>1</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>1</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6677511</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">2877511</PMID><DateCompleted><Year>1986</Year><Month>12</Month><Day>08</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>41</Volume><Issue>3</Issue><PubDate><Year>1986</Year><Month>Nov</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Di-n-octyl
        phthalate (DOP), a relatively ineffective peroxisome inducing straight chain
        isomer of the environmental contaminant di(2-ethylhexyl)phthalate (DEHP),
        enhances the development of putative preneoplastic lesions in rat liver.</ArticleTitle><Pagination><StartPage>279</StartPage><EndPage>288</EndPage><MedlinePgn>279-88</MedlinePgn></Pagination><Abstract><AbstractText>Di-n-octyl
        phthalate (DOP) is the straight chain isomer of di(2-ethylhexyl) phthalate
        (DEHP) which is a widely used plasticizer and an environmental contaminant.
        DEHP is a strong inducer of peroxisome proliferation in rat liver. This is
        significant since other compounds which are strong inducers of peroxisome
        proliferation have been reported to be weak carcinogens (Reddy, J.K. and Lalwani,
        N.D., CRC Crit. Rev. Toxicol., 12 (1983) 1). In contrast to DEHP, DOP causes
        little or no induction of liver peroxisomes (Mann, A.H. et al., Toxicol. Appl.
        Pharmacol., 77 (1985) 116, and Gray, T.J.B. et al., Toxicology, 28 (1983)
        167). In the current study the ability of 1% DOP to promote the development
        of putative preneoplastic lesions was evaluated. The effect of feeding 0.5%
        DEHP as well as equimolar amounts of its 2 major metabolites, mono(2-ethylhexyl)phthalate
        (MEHP) and 2-ethylhexanol (2-EH) were also investigated. GGT+ foci were initiated
        in the livers of Sprague--Dawley male rats with a single dose of diethylnitrosamine
        (DEN) following partial hepatectomy. The control group of rats was fed a semipurified
        diet (Co) for 10 weeks while the experimental groups received the semipurified
        diet containing the respective compounds. Induction of peroxisome proliferation
        was monitored by carnitine acetyltransferase (CAT) levels. DOP treatment resulted
        in a 6-fold increase in the number of GGT+ foci (20.8 +/- 4.0 vs. 3.5 +/-
        1.3; P less than 0.05). This was accompanied by no change in liver weight
        and only a slight increase in CAT activity when compared with control animals.
        In contrast to DOP, 2-EH produced essentially no effect with regard to number
        of foci, peroxisome proliferation or liver weight. DEHP and MEHP induced significant
        peroxisome proliferation and hepatomegaly but the number of foci were significantly
        lower than in 2-EH-treated rats. The mechanism for the promoting ability of
        DOP is not clear but would not appear to be related to peroxisome proliferation.
        Because of the close similarity of chemical structure and metabolism between
        DOP and DEHP, it is possible that studies to define the mechanism of DOP induced
        promotion might also serve to further clarify the mechanism of DEHP induced
        carcinogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>DeAngelo</LastName><ForeName>A B</ForeName><Initials>AB</Initials></Author><Author
        ValidYN="Y"><LastName>Garrett</LastName><ForeName>C T</ForeName><Initials>CT</Initials></Author><Author
        ValidYN="Y"><LastName>Manolukas</LastName><ForeName>L A</ForeName><Initials>LA</Initials></Author><Author
        ValidYN="Y"><LastName>Yario</LastName><ForeName>T</ForeName><Initials>T</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>1-R01-CA-31324</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>8X3RJ0527W</RegistryNumber><NameOfSubstance
        UI="C010715">di-n-octyl phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.2.2</RegistryNumber><NameOfSubstance UI="D005723">gamma-Glutamyltransferase</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011230" MajorTopicYN="N">Precancerous Conditions</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005723" MajorTopicYN="N">gamma-Glutamyltransferase</DescriptorName><QualifierName
        UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>11</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">2877511</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(86)90182-4</ArticleId><ArticleId
        IdType="pii">0300-483X(86)90182-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6143560</PMID><DateCompleted><Year>1984</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>7</Issue><PubDate><Year>1984</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Induction
        of rat hepatic long-chain acyl-CoA hydrolases by various peroxisome proliferators.</ArticleTitle><Pagination><StartPage>1081</StartPage><EndPage>1085</EndPage><MedlinePgn>1081-5</MedlinePgn></Pagination><Abstract><AbstractText>Induction
        of cytosolic long-chain acyl-CoA hydrolases was investigated in rat liver
        after administration of various peroxisome proliferators and related compounds.
        Treatment of rats with di-(2-ethylhexyl)-phthalate, di-(2-ethylhexyl)-adipate
        or tiadenol induced hydrolases I and II, while acetylsalicylic acid induced
        only hydrolase II. Among the various phenoxyacetic acid derivatives and related
        compounds, 2,4,5-trichlorophenoxyacetic acid, 2-(4-chlorophenoxy)-2-methylacetic
        acid, 2-(2-chlorophenoxy)-2-methylpropionic acid and clofibric acid induced
        both hydrolases I and II, whereas 2, 4-dichlorophenoxyacetic acid induced
        only hydrolase II. All nine of the above-mentioned inducers also markedly
        increased the activity of peroxisomal beta-oxidation. Other compounds tested
        (2-chlorophenoxyacetic acid, 4-chlorophenoxyacetic acid, 4-chlorophenol, phenoxyacetic
        acid and phenoxy-2-methylacetic acid) were ineffective as inducers. These
        results suggest that inducers of acyl-CoA hydrolase II also enhance peroxisomal
        beta-oxidation activity, but do not necessarily induce acyl-CoA hydrolase
        I. The structure-inducing activity relationships of these compounds are discussed.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Katoh</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Nakajima</LastName><ForeName>S</ForeName><Initials>S</Initials></Author><Author
        ValidYN="Y"><LastName>Kawashima</LastName><ForeName>Y</ForeName><Initials>Y</Initials></Author><Author
        ValidYN="Y"><LastName>Kozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Uchiyama</LastName><ForeName>M</ForeName><Initials>M</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005233">Fatty Alcohols</NameOfSubstance></Chemical><Chemical><RegistryNumber>22251270CX</RegistryNumber><NameOfSubstance
        UI="C004568">tiadenol</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.2.-</RegistryNumber><NameOfSubstance UI="D013869">Thiolester Hydrolases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.1.2.2</RegistryNumber><NameOfSubstance UI="D010170">Palmitoyl-CoA Hydrolase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005233" MajorTopicYN="N">Fatty Alcohols</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="Y">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010170" MajorTopicYN="N">Palmitoyl-CoA Hydrolase</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013869" MajorTopicYN="N">Thiolester Hydrolases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1984</Year><Month>4</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1984</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6143560</ArticleId><ArticleId IdType="doi">10.1016/0006-2952(84)90517-3</ArticleId><ArticleId
        IdType="pii">0006-2952(84)90517-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3709451</PMID><DateCompleted><Year>1986</Year><Month>07</Month><Day>03</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0091-6765</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><PubDate><Year>1986</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Environmental
        health perspectives</Title><ISOAbbreviation>Environ Health Perspect</ISOAbbreviation></Journal><ArticleTitle>Studies
        on the genetic effects of phthalic acid esters on cells in culture.</ArticleTitle><Pagination><StartPage>263</StartPage><EndPage>266</EndPage><MedlinePgn>263-6</MedlinePgn></Pagination><Abstract><AbstractText>Mono(2-ethylhexyl)
        phthalate (MEHP) induced chromosome aberrations in cells of two culture lines,
        one derived from Chinese hamster ovary cells (CHO) and the other from rat
        liver cells (RL4). In CHO cells, the clastogenicity of MEHP was unaffected
        by the presence of an exogenous metabolic activation system (S-9 mix). 2-Ethylhexanol,
        o-phthalic acid, and phthalic anhydride were without effect. Cytochemical
        methods and assays for carnitine acetyltransferase and KCN-insensitive palmitoyl
        CoA oxidation were employed to determine whether chromosome damage was associated
        with peroxisome proliferation. No evidence of an increase in peroxisome numbers
        or of induction of marker enzymes was found in CHO cells treated with MEHP
        for up to 72 hr. Clofibric acid and BR931 were also ineffective. Observations
        on changes in CHO cell structure and permeability, and on the haemolytic effects
        of phthalate monoesters, suggest that the cytotoxicity of MEHP may be due
        primarily to its action on cell membranes. Since chromosome damage was observed
        only at cytotoxic concentrations, it is suggested that damage to lysosomal
        membranes and the release of endonucleases may be responsible for the observed
        clastogenicity of MEHP in vitro.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Phillips</LastName><ForeName>B J</ForeName><Initials>BJ</Initials></Author><Author
        ValidYN="Y"><LastName>Anderson</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Gangolli</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Health Perspect</MedlineTA><NlmUniqueID>0330411</NlmUniqueID><ISSNLinking>0091-6765</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002462" MajorTopicYN="N">Cell Membrane</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002463" MajorTopicYN="N">Cell Membrane Permeability</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002869" MajorTopicYN="N">Chromosome Aberrations</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002875" MajorTopicYN="N">Chromosomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006461" MajorTopicYN="N">Hemolysis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010053" MajorTopicYN="N">Ovary</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1986</Year><Month>3</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pmc-release"><Year>1986</Year><Month>3</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3709451</ArticleId><ArticleId IdType="pmc">PMC1474679</ArticleId><ArticleId
        IdType="doi">10.1289/ehp.8665263</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nature.
        1965 Sep 11;207(5002):1170-3</Citation><ArticleIdList><ArticleId IdType="pubmed">5882717</ArticleId></ArticleIdList></Reference><Reference><Citation>Nature.
        1970 Aug 15;227(5259):707-8</Citation><ArticleIdList><ArticleId IdType="pubmed">4914590</ArticleId></ArticleIdList></Reference><Reference><Citation>J
        Chromatogr. 1973 Feb 28;76(2):321-30</Citation><ArticleIdList><ArticleId IdType="pubmed">4689606</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1975 Dec;31(6):347-64</Citation><ArticleIdList><ArticleId IdType="pubmed">768755</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1977 Oct;45(1):91-101</Citation><ArticleIdList><ArticleId IdType="pubmed">917038</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1979 Oct;64(5):329-37</Citation><ArticleIdList><ArticleId IdType="pubmed">117353</ArticleId></ArticleIdList></Reference><Reference><Citation>Exp
        Cell Res. 1965 Apr;38:144-52</Citation><ArticleIdList><ArticleId IdType="pubmed">14277325</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:119-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6814903</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:35-40</Citation><ArticleIdList><ArticleId IdType="pubmed">6754363</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1982 Oct-Nov;102(3):297-304</Citation><ArticleIdList><ArticleId IdType="pubmed">6890626</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1983 Jan;67(1):15-25</Citation><ArticleIdList><ArticleId IdType="pubmed">6845354</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutat
        Res. 1984 May;126(3):265-71</Citation><ArticleIdList><ArticleId IdType="pubmed">6325900</ArticleId></ArticleIdList></Reference><Reference><Citation>Toxicol
        Appl Pharmacol. 1974 Jul;29(1):35-46</Citation><ArticleIdList><ArticleId IdType="pubmed">4283679</ArticleId></ArticleIdList></Reference><Reference><Citation>Environ
        Health Perspect. 1982 Nov;45:115-8</Citation><ArticleIdList><ArticleId IdType="pubmed">7140683</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3934796</PMID><DateCompleted><Year>1986</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>37</Volume><Issue>3-4</Issue><PubDate><Year>1985</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Distribution
        and retention of some chlorinated hydrocarbons and a phthalate in the mouse
        brain during the pre-weaning period.</ArticleTitle><Pagination><StartPage>189</StartPage><EndPage>203</EndPage><MedlinePgn>189-203</MedlinePgn></Pagination><Abstract><AbstractText>In
        a quantitative retaining study and a whole-body autoradiographic study 5 14C-labelled
        compounds, bis-(4-chlorophenyl)trichloroethane (DDT), 2,2'',4,4'',5,5''-hexachlorobiphenyl
        (6-CB), hexachlorophene (HCP), polychlorohexadecane (PCHD) and diethylhexylphthalate
        (DEHP) were each administered to mice at the age of 3, 10 and 20 days. The
        mice were killed 24 h or 7 days after treatment and the amount of radioactivity
        in the whole brain was measured and its distribution studied. The retention
        of radioactivity was most pronounced in mice receiving DDT, PCHD, and 6-CB
        during the tenth day of life. Here the level of radioactivity 7 days after
        treatment was nearly as high as that observed after 24 h (ratio between 0.86
        and 0.74). In contrast, HCP showed a rapid elimination from the brain and
        was hardly retained at all in the 20-day-old mouse brain. The retention of
        DEHP in the brain was minimal. Some of the autoradiographic sections were
        also subjected to myelin staining. Large amounts of radioactivity were found
        in the myelinated areas of the brain after HCP and PCHD administration. DDT
        and 6-CB showed a more even distribution within the brain and were not particularly
        concentrated in the myelin. There was no obvious relationship between the
        lipophilicity of the parent compounds and their retention in the brain.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Eriksson</LastName><ForeName>P</ForeName><Initials>P</Initials></Author><Author
        ValidYN="Y"><LastName>Darnerud</LastName><ForeName>P O</ForeName><Initials>PO</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002250">Carbon Radioisotopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>DFC2HB4I0K</RegistryNumber><NameOfSubstance
        UI="D011078">Polychlorinated Biphenyls</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000375" MajorTopicYN="N">Aging</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000831" MajorTopicYN="N">Animals, Newborn</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001345" MajorTopicYN="N">Autoradiography</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002250" MajorTopicYN="N">Carbon Radioisotopes</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009186" MajorTopicYN="N">Myelin Sheath</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011078" MajorTopicYN="N">Polychlorinated Biphenyls</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014018" MajorTopicYN="N">Tissue Distribution</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1985</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1985</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3934796</ArticleId><ArticleId IdType="doi">10.1016/0300-483x(85)90082-4</ArticleId><ArticleId
        IdType="pii">0300-483X(85)90082-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8761421</PMID><DateCompleted><Year>1996</Year><Month>10</Month><Day>01</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>12</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>17</Volume><Issue>8</Issue><PubDate><Year>1996</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Hepatocyte
        expression of tumor associated aldehyde dehydrogenase (ALDH-3) and p21 Ras
        following diethylnitrosamine (DEN) initiation and chronic exposure to di(2-ethylhexyl)phthalate
        (DHEP).</ArticleTitle><Pagination><StartPage>1647</StartPage><EndPage>1655</EndPage><MedlinePgn>1647-55</MedlinePgn></Pagination><Abstract><AbstractText>Phthalate
        esters such as di(2-ethylhexyl)phthalate (DEHP) either promote or inhibit
        rat liver tumorigenesis depending on the carcinogenesis protocol. In this
        study, we examined the expression of two histochemical markers, the tumor
        associated isozyme of aldehyde dehydrogenase (ALDH-3) and the oncoprotein
        p21 Ras, in the livers of male F344 rats. The rats were initiated with DEN
        and further treated with either DEHP (a known inhibitor of hepatocarcinogenesis),
        phenobarbital (PB, a known promoter of hepatocarcinogenesis), or a combination
        of DEHP and PB. The studies were designed to examine the expression of these
        markers in both normal appearing liver and hepatic hyperplastic and neoplastic
        lesions and to correlate the early expression of the markers at 26 weeks in
        the normal appearing liver to later tumor incidence at 52 weeks. The expression
        of each marker was detected by immunohistochemical methods on formalin-fixed
        paraffin embedded sections of normal appearing liver or liver lesions. We
        found that ALDH-3 and p21 expression were significantly enhanced in rats receiving
        PB after DEN initiation at 26 weeks and that the incidence of hepatocellular
        carcinomas was likewise increased compared to control or DEN only treated
        animals. DEN initiation followed by a combination of PB and either 0.1 or
        0.5% DEHP significantly reduced ALDH-3 but not p21 Ras expression at 26 weeks
        compared to DEN plus PB only. These treatment regimens also reduced the incidence
        of hepatocellular carcinomas at 52 weeks. DEN followed by any of the three
        doses of DEHP without PB resulted in ALDH-3 expression similar to DEN alone.
        However, p21 Ras expression was significantly increased after these treatments.
        For all treatment groups, both the early (26 weeks) expression of p21 Ras
        and ALDH-3 correlated with hepatocellular carcinoma incidence at 52 weeks.
        However, the correlation between hepatocellular carcinoma and ALDH-3 expression
        was better than p21 Ras or the other markers we have studied. We concluded
        that ALDH-3 expression is significantly downregulated after DEHP treatment,
        and that expression of the isozyme correlated with later hepatocarcinoma incidence
        and may indicate a significant relationship between ALDH-3 expression and
        hepatocarcinogenesis during DEHP treatment.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Richmond</LastName><ForeName>R
        E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Northern
        Kentucky University, Department of Biological Sciences, Highland Heights,
        KY 41099, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>J
        H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Carter</LastName><ForeName>H
        W</ForeName><Initials>HW</Initials></Author><Author ValidYN="Y"><LastName>Daniel</LastName><ForeName>F
        B</ForeName><Initials>FB</Initials></Author><Author ValidYN="Y"><LastName>Deangelo</LastName><ForeName>A
        B</ForeName><Initials>AB</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014408">Biomarkers, Tumor</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D007527">Isoenzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>3IQ78TTX1A</RegistryNumber><NameOfSubstance
        UI="D004052">Diethylnitrosamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.2.1.3</RegistryNumber><NameOfSubstance UI="D000444">Aldehyde Dehydrogenase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        3.6.5.2</RegistryNumber><NameOfSubstance UI="D016283">Proto-Oncogene Proteins
        p21(ras)</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000444" MajorTopicYN="N">Aldehyde Dehydrogenase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014408" MajorTopicYN="N">Biomarkers, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004052" MajorTopicYN="N">Diethylnitrosamine</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006529" MajorTopicYN="N">Hepatomegaly</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007527" MajorTopicYN="N">Isoenzymes</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D016283" MajorTopicYN="N">Proto-Oncogene Proteins p21(ras)</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1996</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8761421</ArticleId><ArticleId IdType="doi">10.1093/carcin/17.8.1647</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">10357793</PMID><DateCompleted><Year>1999</Year><Month>07</Month><Day>22</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>20</Volume><Issue>6</Issue><PubDate><Year>1999</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Hepatic
        hyperplasia and cancer in rats: alterations in copper metabolism.</ArticleTitle><Pagination><StartPage>1091</StartPage><EndPage>1096</EndPage><MedlinePgn>1091-6</MedlinePgn></Pagination><Abstract><AbstractText>We
        previously demonstrated that rats exposed to the peroxisome proliferator (PP)
        diethylhexylphthalate (DEHP) had reduced serum ceruloplasmin (CP) oxidase
        activity, which suggests tissue copper deposition. Copper is highly toxic
        in excess, and results in cellular damage and hepatocellular carcinomas (HCC).
        This study addresses changes in expression of copper-related genes and metal
        accumulation in hyperplastic liver and tumors induced by PP. Male rats were
        fed diets containing DEHP or clofibrate (CLF) for 3-60 days (hyperplasia)
        and 4-chloro-6-(2,3 xylidino)-2-pyrimidinyl-thio(N-beta-hydroxyethyl) acetamide
        for 10 months (HCC). During hyperplasia, an immediate and progressive decrease
        in serum CP activity was observed (P &lt; 0.05), as were reductions in mRNA
        levels for both CP and Wilson''s disease gene (WD gene, a P-type ATPase) (P
        &lt; 0.05). Tumor-bearing rats had lower serum CP activity (P &lt; 0.05),
        and CP and WD gene mRNA levels were reduced in tumors (P &lt; 0.05), and in
        liver surrounding tumors (SL) (P &lt; 0.05). Metallothionein mRNA showed no
        consistent changes during hyperplasia. Tumors showed a 2.5-fold induction
        of metallothionein mRNA (P &lt; 0.05), and a 1.2-fold increase in SL. Temporal
        increases in liver copper content occurred during hyperplasia, with increases
        of 2-fold (DEHP) and 3.3-fold (CLF) at 60 days (P &lt; 0.05). Copper content
        was 2.2-fold higher in tumors (P &lt; 0.05) and 1.7-fold higher in SL; iron
        did not increase and zinc decreased temporally. Thus, copper accumulation
        and changes in copper-related gene expression may be contributing factors
        in liver neoplasia in PP-treated rats. Loss of CP results in decreased free
        radical scavenger capacity and thus may enhance oxidative damage induced by
        PPs.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Eagon</LastName><ForeName>P
        K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>VA Medical
        Center, Pittsburgh, PA 15240, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Teepe</LastName><ForeName>A G</ForeName><Initials>AG</Initials></Author><Author
        ValidYN="Y"><LastName>Elm</LastName><ForeName>M S</ForeName><Initials>MS</Initials></Author><Author
        ValidYN="Y"><LastName>Tadic</LastName><ForeName>S D</ForeName><Initials>SD</Initials></Author><Author
        ValidYN="Y"><LastName>Epley</LastName><ForeName>M J</ForeName><Initials>MJ</Initials></Author><Author
        ValidYN="Y"><LastName>Beiler</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Shinozuka</LastName><ForeName>H</ForeName><Initials>H</Initials></Author><Author
        ValidYN="Y"><LastName>Rao</LastName><ForeName>K N</ForeName><Initials>KN</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA53453</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>53PF01Q249</RegistryNumber><NameOfSubstance
        UI="D002995">Clofibric Acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>789U1901C5</RegistryNumber><NameOfSubstance
        UI="D003300">Copper</NameOfSubstance></Chemical><Chemical><RegistryNumber>9038-94-2</RegistryNumber><NameOfSubstance
        UI="D008668">Metallothionein</NameOfSubstance></Chemical><Chemical><RegistryNumber>969LVT6GJ2</RegistryNumber><NameOfSubstance
        UI="C016908">pirinixil</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.16.3.1</RegistryNumber><NameOfSubstance UI="D002570">Ceruloplasmin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002570" MajorTopicYN="N">Ceruloplasmin</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002995" MajorTopicYN="N">Clofibric Acid</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003300" MajorTopicYN="N">Copper</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006965" MajorTopicYN="N">Hyperplasia</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName
        UI="Q000473" MajorTopicYN="Y">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="N">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008668" MajorTopicYN="N">Metallothionein</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName
        UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1999</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1999</Year><Month>6</Month><Day>5</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">10357793</ArticleId><ArticleId IdType="doi">10.1093/carcin/20.6.1091</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">20358181</PMID><DateCompleted><Year>2011</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1432-0738</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>85</Volume><Issue>1</Issue><PubDate><Year>2011</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Archives
        of toxicology</Title><ISOAbbreviation>Arch Toxicol</ISOAbbreviation></Journal><ArticleTitle>26-Week
        carcinogenicity study of di-isodecyl phthalate by dietary administration to
        CB6F1-rasH2 transgenic mice.</ArticleTitle><Pagination><StartPage>59</StartPage><EndPage>66</EndPage><MedlinePgn>59-66</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1007/s00204-010-0536-6</ELocationID><Abstract><AbstractText>This
        study examined the carcinogenic potential of di-isodecyl phthalate (DIDP)
        in rasH2 mice. DIDP was administered to 15 rasH2 mice/gender/group at dietary
        levels of 0, 0.1, 0.33, or 1% and 15 wild-type mice/gender/group at dietary
        levels of 0 and 1% for 26 weeks. Non-neoplastic changes were observed in the
        liver (parenchymal inflammation, fatty changes, diffuse hepatocyte hypertrophy
        with eosinophilic granules and focal necrosis) and kidneys (tubular basophilia
        and tubular hyperplasia) after administration of DIDP in the rasH2 and wild-type
        mice. In the neoplastic lesions, there were a higher number of hepatocellular
        adenomas in the male rasH2 mice receiving 1% DIDP, compared with the findings
        in the liver of control rasH2 mice or wild-type mice. The incidence of hepatocellular
        adenomas in the 0.1, 0.33, and 1% DIDP exposed rasH2 mice was 7% (1/15), 7%
        (1/15), and 33% (5/15), respectively. This study adds a set of results for
        an additional test chemical for the performance of the rasH2 short-term transgenic
        model to the existing database of 3 compounds (WY-14643, DEHP, and clofibrate)
        tested in the ILSI/HESI ACT project.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Wan-Seob</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Centre
        for Inflammation Research, The Queen''s Medical Research Institute, The University
        of Edinburgh, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeong</LastName><ForeName>Jayoung</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Choi</LastName><ForeName>Mina</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Park</LastName><ForeName>Sue Nie</ForeName><Initials>SN</Initials></Author><Author
        ValidYN="Y"><LastName>Han</LastName><ForeName>Beom Seok</ForeName><Initials>BS</Initials></Author><Author
        ValidYN="Y"><LastName>Son</LastName><ForeName>Woo-Chan</ForeName><Initials>WC</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2010</Year><Month>04</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Arch
        Toxicol</MedlineTA><NlmUniqueID>0417615</NlmUniqueID><ISSNLinking>0340-5761</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>684-93-5</RegistryNumber><NameOfSubstance
        UI="D008770">Methylnitrosourea</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>HPN91K7FU3</RegistryNumber><NameOfSubstance
        UI="D002994">Clofibrate</NameOfSubstance></Chemical><Chemical><RegistryNumber>WF93T741QI</RegistryNumber><NameOfSubstance
        UI="C042080">diisodecyl phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D018248" MajorTopicYN="N">Adenoma, Liver Cell</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002994" MajorTopicYN="N">Clofibrate</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011905" MajorTopicYN="N">Genes, ras</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008770" MajorTopicYN="N">Methylnitrosourea</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="N">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2009</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2010</Year><Month>3</Month><Day>18</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2010</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">20358181</ArticleId><ArticleId IdType="doi">10.1007/s00204-010-0536-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">6355494</PMID><DateCompleted><Year>1983</Year><Month>12</Month><Day>17</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0098-4108</ISSN><JournalIssue
        CitedMedium="Print"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>1983</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health</Title><ISOAbbreviation>J Toxicol Environ
        Health</ISOAbbreviation></Journal><ArticleTitle>The carcinogenicity of di(2-ethylhexyl)
        phthalate (DEHP) in perspective.</ArticleTitle><Pagination><StartPage>159</StartPage><EndPage>169</EndPage><MedlinePgn>159-69</MedlinePgn></Pagination><Abstract><AbstractText>The
        commonly used plasticizer di(2-ethylhexyl) phthalate (DEHP) was recently tested
        for chronic toxic potential by incorporation into the diet of rats and mice
        for approximately 2 yr. Upon reviewing the test results, the sponsoring organization
        concluded that DEHP was carcinogenic to the rats and mice, as indicated by
        increased occurrences of liver tumors in the DEHP-exposed animals in comparison
        to controls. Another group has disagreed with this conclusion, however, citing
        perceived methodological deficiencies and improper interpretations in the
        study, and has also suggested that rodents may not be adequate models of human
        response to DEHP. This communication compares the conduct of the DEHP bioassay
        favorably with state-of-the-art procedures in animal carcinogenicity testing
        and documents approval of the study interpretations by several independent
        peer review groups. The carcinogenic potential of DEHP is placed in perspective
        by evaluating the evidence for DEHP-induced tumors in rodent species in light
        of dose response relationships, other biochemical and toxicological effects
        of DEHP, and its comparative metabolism and disposition in rodent and primate
        species. A composite analysis of the currently available information indicates
        that DEHP has been shown to be carcinogenic to rodents in a valid chronic
        test, indicating that it should be considered as a potential carcinogen in
        humans, as well. Further experimental inquiry will be required, however, to
        accurately assess the potential health risks posed to humans by exposure to
        small amounts of this plasticizer.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kluwe</LastName><ForeName>W M</ForeName><Initials>WM</Initials></Author><Author
        ValidYN="Y"><LastName>Haseman</LastName><ForeName>J K</ForeName><Initials>JK</Initials></Author><Author
        ValidYN="Y"><LastName>Huff</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>J Toxicol Environ Health</MedlineTA><NlmUniqueID>7513622</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010968">Plasticizers</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006168" MajorTopicYN="N">Guinea Pigs</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008452" MajorTopicYN="N">Maximum Allowable Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008722" MajorTopicYN="N">Methods</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009374" MajorTopicYN="N">Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009928" MajorTopicYN="N">Organ Specificity</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010968" MajorTopicYN="N">Plasticizers</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>35</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1983</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1983</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">6355494</ArticleId><ArticleId IdType="doi">10.1080/15287398309530414</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">8998951</PMID><DateCompleted><Year>1997</Year><Month>01</Month><Day>17</Day></DateCompleted><DateRevised><Year>2019</Year><Month>09</Month><Day>09</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0272-0590</ISSN><JournalIssue
        CitedMedium="Print"><Volume>31</Volume><Issue>1</Issue><PubDate><Year>1996</Year><Month>May</Month></PubDate></JournalIssue><Title>Fundamental
        and applied toxicology : official journal of the Society of Toxicology</Title><ISOAbbreviation>Fundam
        Appl Toxicol</ISOAbbreviation></Journal><ArticleTitle>Oncogenicity testing
        of 2-ethylhexanol in Fischer 344 rats and B6C3F1 mice.</ArticleTitle><Pagination><StartPage>29</StartPage><EndPage>41</EndPage><MedlinePgn>29-41</MedlinePgn></Pagination><Abstract><AbstractText>2-Ethylhexanol
        (2EH) is a weak nongenotoxic hepatic peroxisome proliferator in the rat. It
        is a high-volume chemical intermediate in the preparation of the plasticizers
        bis-(2-ethylhexyl) adipate (DEHA), bis-(2-ethylhexyl) phthalate (DEHP), and
        tris-(2-ethylhexyl) phosphate (TEHP), which are weak hepatocellular tumorigens
        in female mice. In consequence, the oncogenic potential of 2EH was evaluated
        in male (M) and female (F) rats and mice (50 animals/sex/group). Oral gavage
        doses of 2EH in 0.005% aqueous Cremophor EL (polyoxyl-35 castor oil) were
        given five times a week to rats: 0 (water), 0 (vehicle), 50, 150, and 500
        mg/kg for 24 months, and to mice: 0 (water), 0 (vehicle), 50, 200, and 750
        mg/kg for 18 months. Statistical comparisons of data were made between vehicle
        controls and treatment groups. There were no differences of biological significance
        between data from vehicle and water control groups. In rats, there were no
        dose-related changes at 50 mg/kg. There was reduced body weight gain at 150
        mg/kg (M, 16; F, 12%) and 500 mg/kg (M, 33; F, 31%) and an increased incidence
        of lethargy and unkemptness. There were dose-related increases in relative
        liver, stomach, brain, kidney, and testis weights at sacrifice. Female rat
        mortality was markedly increased at 500 mg/kg. There was marked aspiration-induced
        bronchopneumonia in rats at 500 mg/kg; hematologic, gross, and microscopic
        changes, including tumors, were otherwise comparable among all rat groups.
        In mice at 50 and 200 mg/kg there were no dose-related changes and essentially
        no time-dependent or time-independent adverse trends in liver tumor incidence
        at the 5% significance level. At 750 mg/kg mouse body weight gain was reduced
        (M, 26; F, 24%), and mortality increased (M and F, 30%) versus vehicle controls.
        At 750 mg/kg there was a slight increase in nonneoplastic focal hyperplasia
        in the forestomach of mice (M 5/50, F 4/50) versus vehicle controls (M 1/50,
        F 1/50). There were increases in mouse relative liver (F, 21%) and stomach
        (M, 13%; F, 19%) weights at 750 mg/kg. There was a 12% incidence of hepatic
        basophilic foci and an 18% incidence of hepatocellular carcinomas in male
        mice at 750 mg/kg, not statistically significant compared with either control
        by Fisher''s exact test. There was a 12% incidence of hepatic basophilic foci
        and a 10% incidence of hepatocellular carcinomas in female mice at 750 mg/kg,
        statistically significant (p &lt; 0.05) compared with vehicle but not with
        water controls by Fisher''s exact test. There were no metastases. Time-dependent
        and -independent statistical analyses showed an adverse trend in the incidence
        of hepatocellular carcinomas in male and female mice, correlated with toxicity
        (expressed as mortality) at 750 mg/kg. The time-adjusted incidence of hepatocellular
        carcinomas in male mice (18.8%) was within the historical normal range at
        the testing facility (0-22%), but that in females (13.1%) lay outside the
        normal range (0-2%). Under the conditions of these studies 2EH was not oncogenic
        in rats, but there were weak adverse trends in hepatocellular carcinoma incidence
        in mice at high dose levels which may have been associated with toxicity.
        The major effects of chronic dosing were mortality in female rats at 500 mg/kg
        and in male and female mice at 750 mg/kg, accompanied by reductions in body
        weight gain in rats at 150 and 500 mg/kg and in mice at 750 mg/kg. Direct
        comparison of any tumorogenic effects of 2EH given alone to female mice with
        those due to 2EH formed in vivo from DEHA, DEHP, or TEHP is limited by the
        high mortality caused by 2ER in female mice at equivalent doses of 2EH. While
        2EH may be a contributing factor in the hepatocellular carcinogenesis in female
        mice associated with the chronic administration of DEHA and DEHP, it is unlikely
        to be the entire proximate carcinogen.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>B
        D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Toxicology
        Research Task Group, Chemical Manufacturers Association, Washington, DC 20037,
        USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gingell</LastName><ForeName>R</ForeName><Initials>R</Initials></Author><Author
        ValidYN="Y"><LastName>Guest</LastName><ForeName>D</ForeName><Initials>D</Initials></Author><Author
        ValidYN="Y"><LastName>Hellwig</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Hodgson</LastName><ForeName>J R</ForeName><Initials>JR</Initials></Author><Author
        ValidYN="Y"><LastName>Kuettler</LastName><ForeName>K</ForeName><Initials>K</Initials></Author><Author
        ValidYN="Y"><LastName>Mellert</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author
        ValidYN="Y"><LastName>Murphy</LastName><ForeName>S R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Sielken</LastName><ForeName>R L</ForeName><Initials>RL</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Tyler</LastName><ForeName>T R</ForeName><Initials>TR</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Fundam Appl Toxicol</MedlineTA><NlmUniqueID>8200838</NlmUniqueID><ISSNLinking>0272-0590</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000441">Hexanols</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014677">Pharmaceutical Vehicles</NameOfSubstance></Chemical><Chemical><RegistryNumber>XZV7TAA77P</RegistryNumber><NameOfSubstance
        UI="C034017">2-ethylhexanol</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001522" MajorTopicYN="N">Behavior, Animal</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001772" MajorTopicYN="N">Blood Cell Count</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015197" MajorTopicYN="N">Carcinogenicity Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000441" MajorTopicYN="N">Hexanols</DescriptorName><QualifierName UI="Q000008"
        MajorTopicYN="N">administration &amp; dosage</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007441" MajorTopicYN="N">Intubation, Gastrointestinal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014677" MajorTopicYN="N">Pharmaceutical Vehicles</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1996</Year><Month>5</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>3</Month><Day>28</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1996</Year><Month>5</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">8998951</ArticleId><ArticleId IdType="doi">10.1006/faat.1996.0073</ArticleId><ArticleId
        IdType="pii">S0272059096900731</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3383337</PMID><DateCompleted><Year>1988</Year><Month>08</Month><Day>03</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>10</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0143-3334</ISSN><JournalIssue
        CitedMedium="Print"><Volume>9</Volume><Issue>7</Issue><PubDate><Year>1988</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Carcinogenesis</Title><ISOAbbreviation>Carcinogenesis</ISOAbbreviation></Journal><ArticleTitle>Failure
        of the peroxisome proliferator WY-14,643 to induce unscheduled DNA synthesis
        in rat hepatocytes following in vivo treatment.</ArticleTitle><Pagination><StartPage>1179</StartPage><EndPage>1183</EndPage><MedlinePgn>1179-83</MedlinePgn></Pagination><Abstract><AbstractText>Peroxisome
        proliferator hepatocarcinogens lack genotoxic activity in numerous in vitro
        assays using non-target cells which do not respond with peroxisome proliferation.
        Therefore, the effect of in vivo treatment with WY-14,643 on DNA repair was
        quantitated in rat hepatocytes, the target cell for carcinogenesis. Palmitoyl
        CoA oxidase and carnitine acetyltransferase activities in isolated hepatocytes
        were elevated by WY-14,643 (50 mg/kg/day by gavage for up to 5 consecutive
        days) and by WY-14,643 (0.1%) or di(2-ethyl-hexyl)phthalate (DEHP) (1.2%)
        feeding (for up to 28 days), indicating peroxisome proliferation had occurred.
        DNA repair as unscheduled DNA synthesis (UDS) was measured autoradiographically
        as net nuclear grains following thymidine incorporation in primary hepatocyte
        cultures. Treatment of rats with WY-14,643 (gavage or feeding) or DEHP (feeding)
        did not induce UDS. Addition of 2-acetylaminofluorene to replicate cultures
        demonstrated that WY-14,643 or DEHP treatment did not prevent repair response.
        Additional cultures were treated with H2O2 (0.8 mM H2O2 3x at 1-h intervals)
        to evaluate the ability of UDS to detect any repair which may be induced by
        peroxisomal metabolism. H2O2 did not induce UDS at this concentration, nor
        did it prevent 2-acetylaminofluorene-induced repair. UDS was, however, observed
        in a separate experiment using a higher concentration of H2O2. In summary,
        a highly carcinogenic peroxisome proliferator did not induce UDS in the target
        cell for carcinogenesis in spite of peroxisome proliferation following in
        vivo treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, NC 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Smith-Oliver</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author
        ValidYN="Y"><LastName>Butterworth</LastName><ForeName>B E</ForeName><Initials>BE</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Carcinogenesis</MedlineTA><NlmUniqueID>8008055</NlmUniqueID><ISSNLinking>0143-3334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9M98QLJ2DL</RegistryNumber><NameOfSubstance
        UI="D015073">2-Acetylaminofluorene</NameOfSubstance></Chemical><Chemical><RegistryNumber>BBX060AN9V</RegistryNumber><NameOfSubstance
        UI="D006861">Hydrogen Peroxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        2.3.1.7</RegistryNumber><NameOfSubstance UI="D002332">Carnitine O-Acetyltransferase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D015073" MajorTopicYN="N">2-Acetylaminofluorene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002332" MajorTopicYN="N">Carnitine O-Acetyltransferase</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="N">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004260" MajorTopicYN="N">DNA Repair</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006861" MajorTopicYN="N">Hydrogen Peroxide</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D066298" MajorTopicYN="N">In Vitro Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000502"
        MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>7</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3383337</ArticleId><ArticleId IdType="doi">10.1093/carcin/9.7.1179</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="Publisher" Owner="NLM"><PMID Version="1">12209194</PMID><DateRevised><Year>2019</Year><Month>11</Month><Day>20</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1521-4621</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>30</Volume><PubDate><Year>1995</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Toxicity
        report series</Title><ISOAbbreviation>Toxic Rep Ser</ISOAbbreviation></Journal><ArticleTitle>NTP
        technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2)
        Administered in Feed to F344/N Rats and B6C3F1 Mice.</ArticleTitle><Pagination><StartPage>1</StartPage><EndPage>G5</EndPage><MedlinePgn>1-G5</MedlinePgn></Pagination><Abstract><AbstractText>Dibutyl
        phthalate is a phthalate ester with extensive use in industry in such products
        as plastic (PVC) piping, various varnishes and lacquers, safety glass, nail
        polishes, paper coatings, dental materials, pharmaceuticals, and plastic food
        wrap. Concomitant with this extensive worldwide use is the high potential
        for human exposure to dibutyl phthalate in the workplace and the home environment
        through direct sources as well as indirectly, through contamination of water,
        air, and foodstuffs. Because existing toxicity information was considered
        inadequate, the effects of exposure to dibutyl phthalate were examined in
        male and female F344/N rats and B6C3F1 mice in 13-week feed studies. Furthermore,
        due to concern over the potential for pervasive exposure of humans to dibutyl
        phthalate, additional perinatal studies examined rats and mice exposed as
        pups in utero, for the 4 weeks of lactation, and for an additional 4 weeks
        postweaning. Additional studies examined the effects on rats of combining
        perinatal and adult subchronic exposure. Due to the recognized biologic activity
        of this and other phthalates, hepatic peroxisome proliferation during the
        in utero and lactational phases and testicular toxicity during the perinatal
        period were also examined. Finally, reproductive assessment by continuous
        breeding (including crossover mating trials and offspring assessment) and
        genetic toxicity studies were also conducted. In the maximum perinatal exposure
        (MPE) determination study in rats, dibutyl phthalate was administered in the
        diet to dams during gestation and lactation, and to the pups postweaning for
        four additional weeks, at concentrations of 0, 1,250, 2,500, 5,000, 7,500,
        10,000, and 20,000 ppm. Decreased weight gains were noted in dams exposed
        to 20,000 ppm during gestation and to dams exposed to 10,000 ppm during lactation.
        The gestation index (number of live pups per breeding female) was significantly
        lower in the 20,000 ppm group than in the controls, and pup mortality in this
        group was marked (100% by Day 1 of lactation); however, survival was 89% or
        greater in all other treatment groups. The mean body weight of pups in the
        10,000 ppm group at Day 28 of lactation was approximately 90% of the mean
        weight of control pups. Pups were weaned onto diets containing dibutyl phthalate
        at the same concentrations fed to dams. After an additional 4 weeks of dietary
        administration, final mean body weights of pups in the 10,000 ppm groups were
        92% of the control value for males and 95% of the control value for females.
        Hepatomegaly (increased relative liver weight) was observed in males in all
        exposed groups and in females receiving 2,500 ppm or greater. No gross lesions
        were observed at necropsy. Moderate hypospermia of the epididymis was diagnosed
        in all male rats in the 7,500 and 10,000 ppm groups; mild hypospermia of the
        epididymis was diagnosed in 2 of 10 males in the 5,000 ppm group. No degeneration
        of the germinal epithelium was detected in the testis of these rats. Thus,
        although toxicologically important, the epididymal hypospermia was not considered
        to be life threatening, and 10,000 ppm was recommended as the MPE concentration
        for male and female rats. In the subsequent subchronic toxicity study of dibutyl
        phthalate with perinatal exposure, dams were administered diets containing
        0 or the MPE concentration (10,000 ppm) during gestation and lactation, and
        weaned pups were administered the same diets as their dams received for an
        additional 4 weeks, until the beginning of the 13-week exposure phase. Male
        and female rats then received diets containing dibutyl phthalate at concentrations
        of 0, 2,500, 5,000, 10,000, 20,000, and 40,000 ppm for 13 weeks. No mortality
        or toxicity was observed in dams during the perinatal phase of the study;
        however, before pups were culled at 4 days postpartum, the percentage of live
        pups per litter was 86% to 93% that of the controls. Through weaning, litter
        weights of exposed pups ranged from 89% to 92% of the control values. Ten
        control and ten exposed pups per sex were examined at the time of trol and
        ten exposed pups per sex were examined at the time of weaning; hepatomegaly
        and markedly increased peroxisomal enzyme activities (approximately 9-fold
        greater than the control values) were observed in exposed pups. Body weights
        of the perinatally exposed pups remained lower than those of the controls
        throughout the 4-week period before the 13-week adult exposures began. During
        the 13-week adult exposure phase, the final mean body weight of males in the
        MPE: 0 ppm control group (MPE rats, returned to the base diet for 13 weeks),
        was 95&amp;percnt; that of the controls. The body weight gain of females in
        the MPE:0 ppm group was greater than that of the unexposed controls, and the
        final body weights of these two groups were similar. Body weight gains of
        rats treated with dibutyl phthalate as adults decreased with increasing exposure
        concentration; for rats that received the MPE concentration followed by 40,000
        ppm for 13 weeks, final body weights were 51&amp;percnt; of the control value
        for males and 74&amp;percnt; of the control value for females. Hepatomegaly
        apparently regressed in rats in the MPE:0 ppm groups but was observed in male
        rats receiving 5,000 ppm or greater and in females receiving 2,500 ppm or
        greater. In males that received 20,000 ppm as adults, testis and epididymal
        weights were less than in the controls; males in the 40,000 ppm group also
        had a lower testis weight than the controls. Results of hematologic analyses
        conducted at the end of the 13-week exposure period suggested a mild anemia
        in male rats administered 10,000 ppm or greater as adults and female rats
        administered 40,000 ppm as adults. Hypocholesterolemia and hypotriglyceridemia
        were observed in male and female rats at the higher exposure concentrations.
        Hypotriglyceridemia was detected in females receiving 20,000 or 40,000 ppm
        and in males receiving 10,000 ppm or greater. Elevations in alkaline phosphatase
        activities and bile acid concentrations in male and female rats receiving
        20,000 or 40,000 ppm as adults were indicative of cholestasis. Microscopic
        examination revealed hepatocellular cytoplasmic alteration, consistent with
        glycogen depletion, in male and female rats receiving a concentration of 10,000
        ppm or greater. In the liver of rats receiving 40,000 ppm, small, fine, eosinophilic
        granules were also observed in the cytoplasm of hepatocytes. Ultrastructural
        examination suggested the presence of increased numbers of peroxisomes. Lipofuscin
        accumulation was detected in rats that received 10,000 ppm or greater. Consistent
        with the regression of the hepatomegaly in rats in the MPE:0 and MPE:2,500
        ppm groups, peroxisomal enzyme activity was not elevated in these groups.
        Marked elevations of peroxisomal enzyme activity were detected, however, in
        males receiving 5,000 ppm or greater and in females receiving 10,000 ppm or
        greater; at the 40,000 ppm concentration, the highest concentration tested,
        enzyme activities were approximately 20 fold greater than the control values.
        Histopathologic examination of the testes revealed degeneration of the germinal
        epithelium, a mild to moderate focal lesion in rats in the 10,000 and 20,000
        ppm groups and a marked, diffuse lesion in all males receiving 40,000 ppm;
        at 40,000 ppm, an almost complete loss of the germinal epithelium resulted.
        Testicular zinc concentrations were lower in the 40,000 ppm group than in
        the controls, a finding consistent with the marked loss of germinal epithelium
        at this exposure concentration. Spermatogenesis was evaluated in rats in the
        0, 2,500, 10,000, and 20,000 ppm groups; rats administered 20,000 ppm had
        fewer spermatid heads per testis than the unexposed controls, and epididymal
        spermatozoal concentration was less than that in the MPE:0 ppm group. For
        comparison with the perinatal subchronic study, a standard 13-week evaluation
        of the toxicity of dibutyl phthalate in male and female rats was also conducted.
        In this study, rats received dibutyl phthalate at the same dietary concentrations
        used in the 13-week exposure phase of the study with perinatal exposure: 0,
        2,500, 5,000, 10,000, 20,000, and 40,000 ppm. No deaths occurred in the standard
        study. Markedly reduced final mean body weights were observed in males and
        females in the 40,000 ppm groups (45&amp;percnt; and 73&amp;percnt; of control
        body weights, respectively); final mean body weights of males receiving 10,000
        ppm or greater and females receiving 20,000 ppm or greater were lower than
        those of the controls. Hepatomegaly was observed in males that received 5,000
        ppm or greater and in females that received 10,000 ppm or greater. Testis
        and epididymal weights of males in the 20,000 and 40,000 ppm groups were lower
        than those of the controls. A minimal anemia was detected in male rats receiving
        5,000 ppm or greater. Hypocholesterolemia was observed in male and female
        rats receiving 20,000 or 40,000 ppm, and hypotriglyceridemia was detected
        in males in all exposed groups and in females receiving 10,000 ppm or greater.
        Elevations in alkaline phosphatase activity and bile acid concentration in
        male and female rats were considered indicative of cholestasis. Morphologic
        evaluation again confirmed the toxicity of dibutyl phthalate to the liver
        and testes of rats. Microscopic examination of the liver revealed hepatocellular
        cytoplasmic alterations, consistent with glycogen depletion, in male and female
        rats receiving 10,000 ppm or greater. In the liver of rats in the 40,000 ppm
        groups, small, fine, eosinophilic granules were also observed in the cytoplasm
        of hepatocytes. Ultrastructural examination suggested the presence of increased
        numbers of peroxisomes, and peroxisomal enzyme activity was elevated in the
        livers of male and female rats administered 5,000 ppm or greater; the enzyme
        activities in the 40,000 ppm groups were approximately 13-fold greater than
        the control value for males and 32-fold greater than the control value for
        females. Lipofuscin accumulation was detected in rats receiving 10,000 ppm
        or greater. Histopathologic examination of the testes revealed degeneration
        of the germinal epithelium, a mild to marked focal lesion in the 10,000 and
        20,000 ppm groups and a marked, diffuse lesion in all males in the 40,000
        ppm group; at 40,000 ppm, an almost complete loss of the germinal epithelium
        resulted. Testicular zinc concentrations were lower in the 20,000 and 40,000
        ppm groups than in the controls. Serum testosterone values were also lower
        at these concentrations than in the controls. Spermatogenesis was evaluated
        in males in the 0, 2,500, 10,000, and 20,000 ppm groups; at 20,000 ppm, spermatid
        heads per testis and per gram testis, epididymal spermatozoal motility, and
        the number of epididymal spermatozoa per gram epididymis were lower than in
        the controls. All of these findings are consistent with the marked loss of
        germinal epithelium at these exposure concentrations. In the continuous breeding
        study, Sprague-Dawley rats received 0, 1,000, 5,000, or 10,000 ppm dibutyl
        phthalate in feed. Mean body weights of exposed dams at delivery and during
        lactation generally decreased with increasing exposure concentration. The
        mean pup weight at birth in the 10,000 ppm group was significantly lower than
        the control pup weight. The average number of live pups per litter in all
        exposed groups was lower than in the controls. Crossover mating trials in
        the F(0) generation revealed no effects on the fertility of male or female
        rats receiving 10,000 ppm. In contrast to the F(0) rats, mating, pregnancy,
        and fertility indices of F(1) rats were lower in the 10,000 ppm group than
        in the controls. Germinal epithelial degeneration of the testes and absence
        or under development of the epididymides were noted in F(1) males in the 10,000
        ppm group. Interstitial cell hyperplasia was noted in 7 of 10 males in the
        10,000 ppm group. These effects document the male and female reproductive
        toxicity of dibutyl phthalate in F(1) rats receiving 10,000 ppm and do not
        exclude the possibility of developmental toxicity to F2 offspring. In the
        MPE determination study in mice, dams received 0, 1,250, 2,500, 5,000, 7,500,
        10,000, or 20,000 ppm dibutyl phthalate in feed during gestation and lactation;
        pups were weaned onto the same diets as the dams received and were exposed
        for an additional 4 weeks. The gestation period was longer in dams that received
        2,500 ppm or greater than in the controls, and gestational body weight gain
        depressions were noted in dams receiving 7,500 ppm or greater. Only 5 of 20
        females in the 10,000 ppm group delivered live pups, and none of the 20 females
        receiving 20,000 ppm delivered live pups. Only one pup in the 10,000 ppm group
        survived past Lactation Day 1; the number of live pups per litter in the 7,500
        ppm group also remained low throughout lactation. No deaths of either male
        or female pups occurred after weaning. Initial (postweaning) and final body
        weights of male pups receiving 2,500 ppm or greater were significantly less
        than those of the control group. The mean body weights of exposed female pups
        were similar to the control body weight at weaning and remained similar throughout
        the 4 weeks postweaning. Hepatomegaly was present in male mice in all exposed
        groups, and the absolute liver weight of males administered 7,500 ppm was
        greater than that of the controls; although a similar change was apparent
        in females, no statistical differences between the liver weights of exposed
        and control females were detected. No treatment-related gross lesions were
        identified at necropsy, and no histopathologic lesions definitively associated
        with treatment were observed in male or female mice in the 7,500 ppm groups.
        The one surviving male pup in the 10,000 ppm group had cytoplasmic alteration
        in the liver, consistent with peroxisome proliferation. Developmental toxicity
        and fetal and pup mortality were suggested at concentrations as low as 7,500
        ppm. No subchronic toxicity study with prior MPE exposure was conducted with
        mice, although an MPE concentration of 5,000 ppm was suggested by the data.
        In a standard 13-week toxicity study, mice received 0, 1,250, 2,500, 5,000,
        10,000, or 20,000 ppm dibutyl phthalate in feed. No deaths occurred during
        this study. Mean body weights and weight gains of male and female mice decreased
        with increasing exposure concentration, and the decreases were significant
        for males and females that received 5,000 ppm or greater. Relative liver weights
        were greater in males and females receiving 5,000 ppm or greater than in the
        controls. A minimal anemia was suggested in female mice in the 20,000 ppm
        group. Although no gross lesions were observed at necropsy, microscopic examination
        revealed hepatocellular cytoplasmic alterations, consistent with glycogen
        depletion, in male mice receiving 10,000 or 20,000 ppm and female mice receiving
        20,000 ppm. Small, fine, eosinophilic granules, consistent with peroxisome
        proliferation, were also observed in the cytoplasm of hepatocytes in males
        and females in the 20,000 ppm groups. Lipofuscin accumulation in the liver
        was detected in mice receiving 10,000 ppm or greater. In a continuous breeding
        study using Swiss (CD-1&amp;reg;) mice, animals received 0, 300, 3,000, or
        10,000 ppm dibutyl phthalate in feed. The fertility index, average number
        of litters per breeding pair, and average number of live pups per litter in
        the 10,000 ppm group were lower than in the controls. Crossover mating trials
        of mice receiving 10,000 ppm revealed effects on dams in the F(0) generation,
        with a lower fertility index, number of live pups per litter, and pup weight
        than in the controls. Liver weights were greater in males and females, and
        the uterine weight was less in exposed dams than in the controls. No other
        changes were observed at necropsy or on histopathologic examination. These
        data document the female reproductive toxicity of dibutyl phthalate in F(0)
        mice. Dibutyl phthalate was not mutagenic in Salmonella typhimurium strain
        TA98, TA100, TA1535, or TA1537 with or without exogenous metabolic activation
        but did induce mutations in L5178Y mouse lymphoma cells treated without metabolic
        activation. In peripheral blood samples obtained from male and female mice
        at the end of the 13-week study, frequencies of micronucleated normochromatic
        erythrocytes were similar between exposed and control mice. Together, the
        studies in rodents suggest that young rodents (in utero and perinatal) respond
        in a manner qualitatively similar to that of adult rats and mice. Dibutyl
        phthalate induced toxic effects in rodents as pups in utero and during the
        lactational phases of development and also affected young adults, as evidenced
        by fetotoxicity and lethality, body weight gain decrements, increased liver
        weights, hepatic peroxisome proliferation, testicular toxicity, and female
        reproductive toxicity. Dibutyl phthalate was lethal to rat fetuses and rat
        and mouse neonates at dietary concentrations that were not toxic to dams.
        Otherwise, there was no teratogenic or morphologic evidence that rodent young
        were uniquely sensitive to the effects of short-term dibutyl phthalate treatment.
        Synonyms: 1,2-Benzenedicarboxylic acid dibutyl ester; benzene-o-dicarboxylic
        acid di-n-butyl ester; o-benzenedicarboxylic acid dibutyl ester; butyl phthalate;
        n-butyl phthalate; DBP; dibutyl 1,2-benzene dicarboxylate; dibutylphthalate;
        di-n-butylphthalate; di(n-butyl) phthalate; dibutyl-o-phthalate; phthalic
        acid dibutyl ester. Trade Names: Celluflex DBP; Elaol; Ergoplast FDB; Ersoplast
        FDA; Genoplast B; Hexaplas M/B; Palatinol C; Polycizer DBP; PX 104; RC Plasticizer
        DBP; Staflex DBP; Uniflex DBP; Unimoll DB; Witcizer 300; Witicizer 300. (NOTE:
        These studies were supported in part by funds from the Comprehensive Environmental
        Response, Compensation, and Liability Act trust fund (Superfund) by an interagency
        agreement with the Agency for Toxic Substances and Disease Registry, U.S.
        Public Health Service.)</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Marsman</LastName><ForeName>Daniel</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxic Rep Ser</MedlineTA><NlmUniqueID>101122696</NlmUniqueID><ISSNLinking>1521-4621</ISSNLinking></MedlineJournalInfo></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>9</Month><Day>5</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1995</Year><Month>4</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12209194</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11995694</PMID><DateCompleted><Year>2002</Year><Month>05</Month><Day>23</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1528-7394</ISSN><JournalIssue
        CitedMedium="Print"><Volume>65</Volume><Issue>8</Issue><PubDate><Year>2002</Year><Month>Apr</Month><Day>26</Day></PubDate></JournalIssue><Title>Journal
        of toxicology and environmental health. Part A</Title><ISOAbbreviation>J Toxicol
        Environ Health A</ISOAbbreviation></Journal><ArticleTitle>Comparative effects
        of phthalate monoesters on gap junctional intercellular communication and
        peroxisome proliferation in rodent and primate hepatocytes.</ArticleTitle><Pagination><StartPage>569</StartPage><EndPage>588</EndPage><MedlinePgn>569-88</MedlinePgn></Pagination><Abstract><AbstractText>Several
        phthalate esters, compounds used as plasticizers in a variety of commercial
        products, have been shown to induce hepatic tumors in rodents. In this study,
        the comparative effects of phthalate monoesters on inhibition of gap junctional
        intercellular communication and induction of peroxisomal beta-oxidation were
        assessed in primary cultured hepatocytes from rats, mice, hamsters, cynomolgus
        monkeys, and humans. A human liver cell line was also utilized. Eight monoesters
        examined included mono-2-ethylhexyl phthalate (MEHP), mono-n-octyl phthalate
        (MNOP), mono-isononyl phthalate (MINP, 3 types, -1, -2, and -3), mono-isoheptyl
        phthalate (MIHP), mono-isodecyl phthalate (MIDP), and mono-(heptyl, nonyl,
        undecyl) phthalate (M711P). Gap junctional intercellular communication was
        measured 4 and 24 h after treatment by lucifer yellow dye coupling. Gap junctional
        intercellular communication was inhibited in rat and mouse hepatocytes by
        all eight monoesters in a concentration-dependent manner. In most cases, gap
        junctional intercellular communication was significantly reduced at the lowest
        concentrations tested (50 pM). Inhibition of gap junctional intercellular
        communication in rodent cells was substantially reversed within 24 h of monoester
        removal. In contrast, cell-to-cell communication was not inhibited in hamster,
        cynomolgus, or human hepatocytes or in a human liver cell line at any concentration
        examined. In rat hepatocytes, peroxisomal beta-oxidation was elevated after
        treatment with MEHP, MINP, MIHP, and MIDP but not MNOP or M711P, and with
        all but MIHP in mouse hepatocytes. The eight phthalates produced no marked
        change on peroxisomal beta-oxidation in hepatocytes from other species. These
        data provide additional evidence that the toxicological effects of phthalate
        esters are species specific.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author
        ValidYN="Y"><LastName>Kamendulis</LastName><ForeName>Lisa M</ForeName><Initials>LM</Initials><AffiliationInfo><Affiliation>Department
        of Pharmacology and Toxicology, Indiana University School of Medicine, Indianapolis
        46202-5120, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Isenberg</LastName><ForeName>Jason
        S</ForeName><Initials>JS</Initials></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Jacqueline
        H</ForeName><Initials>JH</Initials></Author><Author ValidYN="Y"><LastName>Pugh</LastName><ForeName>George</ForeName><Initials>G</Initials><Suffix>Jr</Suffix></Author><Author
        ValidYN="Y"><LastName>Lington</LastName><ForeName>Arthur W</ForeName><Initials>AW</Initials></Author><Author
        ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J
        Toxicol Environ Health A</MedlineTA><NlmUniqueID>100960995</NlmUniqueID><ISSNLinking>0098-4108</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004952">Esters</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>57716-89-9</RegistryNumber><NameOfSubstance
        UI="C020922">4-O-methyl-12-O-tetradecanoylphorbol 13-acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>NI40JAQ945</RegistryNumber><NameOfSubstance
        UI="D013755">Tetradecanoylphorbol Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002450" MajorTopicYN="N">Cell Communication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004952" MajorTopicYN="N">Esters</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017629" MajorTopicYN="N">Gap Junctions</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D022781" MajorTopicYN="N">Hepatocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008815" MajorTopicYN="N">Mice, Inbred Strains</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013329" MajorTopicYN="N">Structure-Activity Relationship</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013755" MajorTopicYN="N">Tetradecanoylphorbol Acetate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="Y">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2002</Year><Month>5</Month><Day>25</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>5</Month><Day>9</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11995694</ArticleId><ArticleId IdType="doi">10.1080/152873902317349736</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">12215663</PMID><DateCompleted><Year>2003</Year><Month>02</Month><Day>27</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>13</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1096-6080</ISSN><JournalIssue
        CitedMedium="Print"><Volume>69</Volume><Issue>1</Issue><PubDate><Year>2002</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Toxicological
        sciences : an official journal of the Society of Toxicology</Title><ISOAbbreviation>Toxicol
        Sci</ISOAbbreviation></Journal><ArticleTitle>Evaluation of a 15-day screening
        assay using intact male rats for identifying antiandrogens.</ArticleTitle><Pagination><StartPage>92</StartPage><EndPage>108</EndPage><MedlinePgn>92-108</MedlinePgn></Pagination><Abstract><AbstractText>An
        in vivo screening assay using intact adult male rats has been evaluated for
        its ability to detect six antiandrogenic compounds via oral administration.
        The test compounds included cyproterone acetate (CPA), flutamide (FLUT), p,p''-DDE
        (DDE), di-n-butyl phthalate (DBP), linuron (LIN), and vinclozolin (VCZ). Two
        of the test compounds (DDE and FLUT) have been previously evaluated in the
        15-day intact male assay with compound administration via intraperitoneal
        injection (ip). For the current studies, male rats were dosed for 15 days
        via oral gavage and euthanized on the morning of test day 15. The endpoints
        evaluated included final body and organ weights (liver, thyroid gland, testes,
        epididymides, prostate, seminal vesicles with fluid, accessory sex gland unit
        [ASG]), serum hormone concentrations (testosterone [T], estradiol [E2], dihydrotestosterone
        [DHT], luteinizing hormone [LH], follicle stimulating hormone [FSH], prolactin
        [PRL], T(3), T(4), and thyroid stimulating hormone[TSH]), and histopathology
        of the testis, epididymis, and thyroid gland; positive results for each endpoint
        are described below. In addition, an evaluation of immune system endpoints
        (humoral immune function, spleen and thymus weights, and spleen cell number)
        was conducted on a subset of animals dosed with either DDE or FLUT. All six
        endocrine-active compounds (EACs) increased relative liver weight. FLUT and
        VCZ caused the typical pattern for an androgen receptor (AR) antagonist, although
        not all endpoints were statistically significant for VCZ: decreased ASG weights,
        hormonal alterations (increased T, DHT, LH, and FSH), and induced Leydig cell
        hypertrophy and/or hyperplasia. CPA caused effects consistent with its mixed
        AR antagonist/progesterone receptor agonist activity: it decreased ASG weights,
        caused hormonal alterations (increased T and E2; decreased FSH), and caused
        spermatid retention. DBP, a compound with antiandrogen-like activity via a
        nonreceptor mediated mechanism, caused hormonal alterations (decreased T,
        DHT, and E2; increased LH, FSH, and PRL) and induced general testicular degeneration.
        LIN, a weak AR antagonist, decreased ASG weights, caused hormonal alterations
        (decreased T, DHT, and LH; increased E2), and caused spermatid retention.
        Unlike the other AR antagonists evaluated, DDE, a weak AR antagonist, did
        not alter reproductive parameters. All six antiandrogens caused some effects
        on thyroid parameters, although only CPA, DDE, and VCZ caused results consistent
        with a potential thyroid-modulator. FLUT and DDE did not alter the primary
        humoral immune response to SRBC, spleen or thymus weights, or spleen cell
        number. In the current study, 5 of the six test substances were identified
        as endocrine-active substances consistent with their known/proposed mechanism(s)
        of action. The effects that were observed in the current study via oral (gavage)
        compound administration were similar to the responses that were observed by
        the ip route in previous studies for DDE and FLUT. This report, in addition
        to the &gt; 20 compounds that have already been examined using the 15-day
        intact male assay, supports this assay as a viable screening assay for detecting
        EACs, and also illustrates that the ability to identify EACs using the intact
        male assay will be equivalent regardless of the route of compound administration.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>O''Connor</LastName><ForeName>John
        C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>DuPont Haskell
        Laboratory for Health and Environmental Sciences, P.O. Box 50, Newark, Delaware
        19714, USA. john.c.oconnor@usa.dupont.com</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Frame</LastName><ForeName>Steven R</ForeName><Initials>SR</Initials></Author><Author
        ValidYN="Y"><LastName>Ladics</LastName><ForeName>Gregory S</ForeName><Initials>GS</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Toxicol Sci</MedlineTA><NlmUniqueID>9805461</NlmUniqueID><ISSNLinking>1096-0929</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000726">Androgen Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000728">Androgens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010080">Oxazoles</NameOfSubstance></Chemical><Chemical><RegistryNumber>01XP1SU59O</RegistryNumber><NameOfSubstance
        UI="D008044">Linuron</NameOfSubstance></Chemical><Chemical><RegistryNumber>4KM2BN5JHF</RegistryNumber><NameOfSubstance
        UI="D017373">Cyproterone Acetate</NameOfSubstance></Chemical><Chemical><RegistryNumber>4M7FS82U08</RegistryNumber><NameOfSubstance
        UI="D003633">Dichlorodiphenyl Dichloroethylene</NameOfSubstance></Chemical><Chemical><RegistryNumber>76W6J0943E</RegistryNumber><NameOfSubstance
        UI="D005485">Flutamide</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>JJ258EZN1I</RegistryNumber><NameOfSubstance
        UI="C025643">vinclozolin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000726" MajorTopicYN="N">Androgen Antagonists</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000728" MajorTopicYN="N">Androgens</DescriptorName><QualifierName UI="Q000097"
        MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D017373" MajorTopicYN="N">Cyproterone Acetate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D003633" MajorTopicYN="N">Dichlorodiphenyl Dichloroethylene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005485" MajorTopicYN="N">Flutamide</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D007107" MajorTopicYN="N">Immune System</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008044" MajorTopicYN="N">Linuron</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010080" MajorTopicYN="N">Oxazoles</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D017207" MajorTopicYN="N">Rats, Sprague-Dawley</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2002</Year><Month>9</Month><Day>7</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2003</Year><Month>2</Month><Day>28</Day><Hour>4</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2002</Year><Month>9</Month><Day>7</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">12215663</ArticleId><ArticleId IdType="doi">10.1093/toxsci/69.1.92</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">1632818</PMID><DateCompleted><Year>1992</Year><Month>08</Month><Day>14</Day></DateCompleted><DateRevised><Year>2019</Year><Month>06</Month><Day>23</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0006-2952</ISSN><JournalIssue
        CitedMedium="Print"><Volume>43</Volume><Issue>12</Issue><PubDate><Year>1992</Year><Month>Jun</Month><Day>23</Day></PubDate></JournalIssue><Title>Biochemical
        pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Microsomal
        lauric acid hydroxylase activities after treatment of rats with three classical
        cytochrome P450 inducers and peroxisome proliferating compounds.</ArticleTitle><Pagination><StartPage>2621</StartPage><EndPage>2629</EndPage><MedlinePgn>2621-9</MedlinePgn></Pagination><Abstract><AbstractText>In
        order to investigate a proposed relationship between induction of hepatic
        microsomal lauric acid hydroxylase activity and peroxisome proliferation in
        the liver, male Wistar rats were treated with peroxisome proliferating compounds,
        and the lauric acid hydroxylase activity, the immunochemical detectable levels
        of cytochrome P450 4A1 and the activities of peroxisomal enzymes were determined.
        In addition, the levels of cytochrome P450 4A1 and lauric acid hydroxylase
        activities were studied after treatment of rats with three cytochrome P450
        inducers. After treatment with aroclor-1254, phenobarbital or 3-methylcholanthrene
        total cytochrome P450 was 1.7-2.7 times induced. However, no induction of
        lauric acid omega-hydroxylase activities or P450 4A1 levels were found. After
        treatment of rats with di(2-ethylhexyl)phthalate (DEHP) a dose-dependent induction
        of lauric acid omega-hydroxylase activities, levels of cytochrome P450 4A1
        and peroxisomal fatty acid beta-oxidation was found. Even at a dose-level
        of 100 mg DEPH/kg body weight per day a significant induction of these activities
        was observed. The main metabolites of DEHP, mono(2-ethylhexyl)phthalate and
        2-ethyl-1-hexanol, also caused an induction of levels of P450 4A1, lauric
        acid omega-hydroxylase activities and the activity of peroxisomal palmitoyl-CoA
        oxidase. 2-Ethyl-1-hexanoic acid did not influence lauric acid omega-hydroxylase
        activities, but did induce levels of P450 4A1 and palmitoyl-CoA oxidase activities.
        Three other compounds (perfluoro-octanoic acid, valproate and nafenopin) induced
        both lauric acid omega-hydroxylase activity and peroxisomal palmitoyl-CoA
        oxidase activity. The plasticizer, di(2-ethylhexyl)adipate, did not induce
        levels of P450 4A1, lauric acid omega-hydroxylase activities or palmitoyl-CoA
        oxidase activities. With the compounds tested a close association between
        the induction of lauric acid omega-hydroxylase activities and peroxisomal
        palmitoyl-CoA oxidase activity was found. These data support the theory that
        peroxisome proliferating compounds do induce lauric acid omega-hydroxylase
        activities and that there might be a mechanistic inter-relationship between
        peroxisome proliferation and induction of lauric acid omega-hydroxylase activities.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Dirven</LastName><ForeName>H
        A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department
        of Toxicology, University of Nijmegen, The Netherlands.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>van den Broek</LastName><ForeName>P H</ForeName><Initials>PH</Initials></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Noordhoek</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author
        ValidYN="Y"><LastName>Jongeneelen</LastName><ForeName>F J</ForeName><Initials>FJ</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem
        Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D000272">Adipates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D001140">Aroclors</NameOfSubstance></Chemical><Chemical><RegistryNumber>093W78U96W</RegistryNumber><NameOfSubstance
        UI="D009255">Nafenopin</NameOfSubstance></Chemical><Chemical><RegistryNumber>11097-69-1</RegistryNumber><NameOfSubstance
        UI="D020111">Chlorodiphenyl (54% Chlorine)</NameOfSubstance></Chemical><Chemical><RegistryNumber>2BD76YG9SI</RegistryNumber><NameOfSubstance
        UI="C013966">dioctyl adipate</NameOfSubstance></Chemical><Chemical><RegistryNumber>56-49-5</RegistryNumber><NameOfSubstance
        UI="D008748">Methylcholanthrene</NameOfSubstance></Chemical><Chemical><RegistryNumber>9035-51-2</RegistryNumber><NameOfSubstance
        UI="D003577">Cytochrome P-450 Enzyme System</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D006899">Mixed Function Oxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.-</RegistryNumber><NameOfSubstance UI="D010088">Oxidoreductases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.14.15.3</RegistryNumber><NameOfSubstance UI="D042926">Cytochrome P-450 CYP4A</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC
        1.3.3.-</RegistryNumber><NameOfSubstance UI="C028427">palmitoyl CoA oxidase</NameOfSubstance></Chemical><Chemical><RegistryNumber>FU2EWB60RT</RegistryNumber><NameOfSubstance
        UI="C016599">mono-(2-ethylhexyl)phthalate</NameOfSubstance></Chemical><Chemical><RegistryNumber>YQE403BP4D</RegistryNumber><NameOfSubstance
        UI="D010634">Phenobarbital</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000272" MajorTopicYN="N">Adipates</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001140" MajorTopicYN="N">Aroclors</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020111" MajorTopicYN="N">Chlorodiphenyl (54% Chlorine)</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D042926" MajorTopicYN="N">Cytochrome P-450 CYP4A</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D003577" MajorTopicYN="N">Cytochrome P-450 Enzyme System</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000031" MajorTopicYN="N">analogs &amp; derivatives</QualifierName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004790" MajorTopicYN="N">Enzyme Induction</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008748" MajorTopicYN="N">Methylcholanthrene</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008862" MajorTopicYN="N">Microsomes, Liver</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000201"
        MajorTopicYN="N">enzymology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006899" MajorTopicYN="N">Mixed Function Oxygenases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009255" MajorTopicYN="N">Nafenopin</DescriptorName><QualifierName UI="Q000494"
        MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009929" MajorTopicYN="N">Organ Size</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010088" MajorTopicYN="N">Oxidoreductases</DescriptorName><QualifierName
        UI="Q000096" MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010634" MajorTopicYN="N">Phenobarbital</DescriptorName><QualifierName
        UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011919" MajorTopicYN="N">Rats, Inbred Strains</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1992</Year><Month>6</Month><Day>23</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1992</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1992</Year><Month>6</Month><Day>23</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">1632818</ArticleId><ArticleId IdType="doi">10.1016/0006-2952(92)90151-8</ArticleId><ArticleId
        IdType="pii">0006-2952(92)90151-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">3180084</PMID><DateCompleted><Year>1988</Year><Month>12</Month><Day>20</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0008-5472</ISSN><JournalIssue
        CitedMedium="Print"><Volume>48</Volume><Issue>23</Issue><PubDate><Year>1988</Year><Month>Dec</Month><Day>01</Day></PubDate></JournalIssue><Title>Cancer
        research</Title><ISOAbbreviation>Cancer Res</ISOAbbreviation></Journal><ArticleTitle>Relationship
        of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenicity
        of the peroxisome proliferators di(2-ethylhexyl)phthalate and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic
        acid (Wy-14,643) in rats.</ArticleTitle><Pagination><StartPage>6739</StartPage><EndPage>6744</EndPage><MedlinePgn>6739-44</MedlinePgn></Pagination><Abstract><AbstractText>The
        mechanism of hepatocarcinogenesis caused by peroxisome proliferators (PP)
        is poorly understood, making it difficult to predict the carcinogenicity of
        PP to rodents or other species. It has been suggested that the carcinogenic
        potential of individual PP in rodents is correlated with the degree of PP-induced
        hepatic peroxisome proliferation. To evaluate this possible correlation, di(2-ethylhexyl)phthalate
        (DEHP) at 1.2% and [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid
        (Wy-14,643) at 0.1% were fed to male F-344 rats for up to 365 days and hepatocytic
        peroxisome proliferation and DNA replication were measured. All rats fed Wy-14,643
        for 365 days had numerous grossly visible nodules in comparison to none in
        the livers of DEHP-fed or control rats. Despite this difference in the induction
        of tumors, both DEHP and Wy-14,643 increased the peroxisomal volume density
        4- to 6-fold from 8 to 365 days of treatment. Peroxisomal beta-oxidation enzyme
        activities were increased 8-fold by both DEHP and Wy-14,643 after 18 days.
        At later time points (77 to 365 days), these enzyme activities were about
        25% higher in livers of Wy-14,643- than DEHP-fed rats. DEHP or Wy-14,643 increased
        absolute liver weights 50 to 75% above controls after 18 to 365 days of feeding.
        Labeling of hepatocyte nuclei with a single injection of tritiated thymidine
        revealed a rapid burst in replicative DNA synthesis in both DEHP and Wy-14,643-fed
        rats, with a return to control levels by 4 days. Additional rats were implanted
        with 7-day osmotic pumps containing tritiated thymidine. With this more extended
        method of labeling a 5- to 10-fold increase in replicative DNA synthesis was
        observed in rats receiving Wy-14,643 for 39 to 365 days as compared to DEHP-fed
        rats or controls. In conclusion, when performed under conditions similar to
        the tumorigenicity studies, the degree of peroxisome proliferation correlated
        poorly with the relative hepatocarcinogenicity of DEHP and Wy-14,643. However,
        a strong correlation was observed between the relative hepatocarcinogenicity
        of DEHP and Wy-14,643 and the ability to induce a persistent increase in replicative
        DNA synthesis. These data emphasize the possible importance of cell replication
        in the mechanism of PP-induced hepatocarcinogenesis.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Marsman</LastName><ForeName>D
        S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Chemical
        Industry Institute of Toxicology, Research Triangle Park, North Carolina 27709.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Cattley</LastName><ForeName>R C</ForeName><Initials>RC</Initials></Author><Author
        ValidYN="Y"><LastName>Conway</LastName><ForeName>J G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Popp</LastName><ForeName>J A</ForeName><Initials>JA</Initials></Author></AuthorList><Language>eng</Language><GrantList
        CompleteYN="Y"><Grant><GrantID>CA 07945</GrantID><Acronym>CA</Acronym><Agency>NCI
        NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013487">Research
        Support, U.S. Gov''t, P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Cancer Res</MedlineTA><NlmUniqueID>2984705R</NlmUniqueID><ISSNLinking>0008-5472</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D010795">Phthalic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D011743">Pyrimidines</NameOfSubstance></Chemical><Chemical><RegistryNumber>86C4MRT55A</RegistryNumber><NameOfSubstance
        UI="C006253">pirinixic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance
        UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001835" MajorTopicYN="N">Body Weight</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002455" MajorTopicYN="N">Cell Division</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000096"
        MajorTopicYN="Y">biosynthesis</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004261" MajorTopicYN="N">DNA Replication</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004435" MajorTopicYN="N">Eating</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008114" MajorTopicYN="N">Liver Neoplasms, Experimental</DescriptorName><QualifierName
        UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010795" MajorTopicYN="N">Phthalic Acids</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011743" MajorTopicYN="N">Pyrimidines</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D011916" MajorTopicYN="N">Rats, Inbred F344</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>1988</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>1988</Year><Month>12</Month><Day>1</Day><Hour>0</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">3180084</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">14727734</PMID><DateCompleted><Year>2004</Year><Month>02</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>18</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">1040-8444</ISSN><JournalIssue
        CitedMedium="Print"><Volume>33</Volume><Issue>6</Issue><PubDate><Year>2003</Year></PubDate></JournalIssue><Title>Critical
        reviews in toxicology</Title><ISOAbbreviation>Crit Rev Toxicol</ISOAbbreviation></Journal><ArticleTitle>PPARalpha
        agonist-induced rodent tumors: modes of action and human relevance.</ArticleTitle><Pagination><StartPage>655</StartPage><EndPage>780</EndPage><MedlinePgn>655-780</MedlinePgn></Pagination><Abstract><AbstractText>Widely
        varied chemicals--including certain herbicides, plasticizers, drugs, and natural
        products--induce peroxisome proliferation in rodent liver and other tissues.
        This phenomenon is characterized by increases in the volume density and fatty
        acid oxidation of these organelles, which contain hydrogen peroxide and fatty
        acid oxidation systems important in lipid metabolism. Research showing that
        some peroxisome proliferating chemicals are nongenotoxic animal carcinogens
        stimulated interest in developing mode of action (MOA) information to understand
        and explain the human relevance of animal tumors associated with these chemicals.
        Studies have demonstrated that a nuclear hormone receptor implicated in energy
        homeostasis, designated peroxisome proliferator-activated receptor alpha (PPARalpha),
        is an obligatory factor in peroxisome proliferation in rodent hepatocytes.
        This report provides an in-depth analysis of the state of the science on several
        topics critical to evaluating the relationship between the MOA for PPARalpha
        agonists and the human relevance of related animal tumors. Topics include
        a review of existing tumor bioassay data, data from animal and human sources
        relating to the MOA for PPARalpha agonists in several different tissues, and
        case studies on the potential human relevance of the animal MOA data. The
        summary of existing bioassay data discloses substantial species differences
        in response to peroxisome proliferators in vivo, with rodents more responsive
        than primates. Among the rat and mouse strains tested, both males and females
        develop tumors in response to exposure to a wide range of chemicals including
        DEHP and other phthalates, chlorinated paraffins, chlorinated solvents such
        as trichloroethylene and perchloroethylene, and certain pesticides and hypolipidemic
        pharmaceuticals. MOA data from three different rodent tissues--rat and mouse
        liver, rat pancreas, and rat testis--lead to several different postulated
        MOAs, some beginning with PPARalpha activation as a causal first step. For
        example, studies in rodent liver identified seven "key events," including
        three "causal events"--activation of PPARalpha, perturbation of cell proliferation
        and apoptosis, and selective clonal expansion--and a series of associative
        events involving peroxisome proliferation, hepatocyte oxidative stress, and
        Kupffer-cell-mediated events. Similar in-depth analysis for rat Leydig-cell
        tumors (LCTs) posits one MOA that begins with PPARalpha activation in the
        liver, but two possible pathways, one secondary to liver induction and the
        other direct inhibition of testicular testosterone biosynthesis. For this
        tumor, both proposed pathways involve changes in the metabolism and quantity
        of related hormones and hormone precursors. Key events in the postulated MOA
        for the third tumor type, pancreatic acinar-cell tumors (PACTs) in rats, also
        begin with PPARalpha activation in the liver, followed by changes in bile
        synthesis and composition. Using the new human relevance framework (HRF) (see
        companion article), case studies involving PPARalpha-related tumors in each
        of these three tissues produced a range of outcomes, depending partly on the
        quality and quantity of MOA data available from laboratory animals and related
        information from human data sources.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Klaunig</LastName><ForeName>James
        E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Indiana University
        School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Babich</LastName><ForeName>Michael A</ForeName><Initials>MA</Initials></Author><Author
        ValidYN="Y"><LastName>Baetcke</LastName><ForeName>Karl P</ForeName><Initials>KP</Initials></Author><Author
        ValidYN="Y"><LastName>Cook</LastName><ForeName>Jon C</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>Corton</LastName><ForeName>J Chris</ForeName><Initials>JC</Initials></Author><Author
        ValidYN="Y"><LastName>David</LastName><ForeName>Raymond M</ForeName><Initials>RM</Initials></Author><Author
        ValidYN="Y"><LastName>DeLuca</LastName><ForeName>John G</ForeName><Initials>JG</Initials></Author><Author
        ValidYN="Y"><LastName>Lai</LastName><ForeName>David Y</ForeName><Initials>DY</Initials></Author><Author
        ValidYN="Y"><LastName>McKee</LastName><ForeName>Richard H</ForeName><Initials>RH</Initials></Author><Author
        ValidYN="Y"><LastName>Peters</LastName><ForeName>Jeffrey M</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Roberts</LastName><ForeName>Ruth A</ForeName><Initials>RA</Initials></Author><Author
        ValidYN="Y"><LastName>Fenner-Crisp</LastName><ForeName>Penelope A</ForeName><Initials>PA</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType><PublicationType UI="D013486">Research
        Support, U.S. Gov''t, Non-P.H.S.</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Crit
        Rev Toxicol</MedlineTA><NlmUniqueID>8914275</NlmUniqueID><ISSNLinking>1040-8444</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D005227">Fatty Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D009687">Nuclear Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D012097">Repressor Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D001681" MajorTopicYN="N">Biological Assay</DescriptorName><QualifierName
        UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000633"
        MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D002471" MajorTopicYN="Y">Cell Transformation, Neoplastic</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004195" MajorTopicYN="Y">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D005227" MajorTopicYN="N">Fatty Acids</DescriptorName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D007984" MajorTopicYN="N">Leydig Cell Tumor</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D015227" MajorTopicYN="N">Lipid Peroxidation</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008099" MajorTopicYN="N">Liver</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008113" MajorTopicYN="N">Liver Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008830" MajorTopicYN="N">Microbodies</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010084" MajorTopicYN="N">Oxidation-Reduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D010179" MajorTopicYN="N">Pancreas</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D010190" MajorTopicYN="N">Pancreatic Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011323" MajorTopicYN="N">Primates</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D012097" MajorTopicYN="N">Repressor Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D013736" MajorTopicYN="N">Testicular Neoplasms</DescriptorName><QualifierName
        UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000503"
        MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013737" MajorTopicYN="N">Testis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016335" MajorTopicYN="N">Zinc Fingers</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>562</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2004</Year><Month>2</Month><Day>26</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2004</Year><Month>1</Month><Day>20</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">14727734</ArticleId><ArticleId IdType="doi">10.1080/713608372</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">23625783</PMID><DateCompleted><Year>2013</Year><Month>08</Month><Day>13</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article
        PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-2280</ISSN><JournalIssue
        CitedMedium="Internet"><Volume>54</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Environmental
        and molecular mutagenesis</Title><ISOAbbreviation>Environ Mol Mutagen</ISOAbbreviation></Journal><ArticleTitle>Diethylhexyl
        phthalate exposure impairs follicular development and affects oocyte maturation
        in the mouse.</ArticleTitle><Pagination><StartPage>354</StartPage><EndPage>361</EndPage><MedlinePgn>354-61</MedlinePgn></Pagination><ELocationID
        EIdType="doi" ValidYN="Y">10.1002/em.21776</ELocationID><Abstract><AbstractText>Diethylhexyl
        phthalate (DEHP) is an estrogen-like compound widely used as a commercial
        plasticizer and present in medical devices, tubing, food containers and packaging.
        It is considered an endocrine disruptor and studies on experimental animals
        showed that exposure to DEHP can alter the function of several organs including
        liver, kidneys, lungs and reproductive system, particularly the developing
        testes of prenatal and neonatal males. Exposure to DEHP has been proposed
        as a potential human health hazard. This study assessed the effects of DEHP
        on folliculogenesis and oocyte maturation using the mouse as the experimental
        model. Newborn female mice were hypodermically injected with DEHP at doses
        of 20 and 40 &#x3bc;g/kg per body weight following different exposure regimens
        during the weaning period. We found that DEHP altered both folliculogenesis
        and oocyte development. In particular, DEHP exposure significantly decreased
        the number of the primordial follicles at pubertal and adult age by possibly
        accelerating the rate of follicle recruitment dynamics, reduced and/or delayed
        the level of imprinted gene methylation in the oocytes and increased metaphase
        II spindle abnormalities in oocytes matured in vitro. Furthermore, the weight
        of pups and litter size of mothers exposed to DEHP were significantly lower
        than controls. Finally, the number of primordial follicles appeared significantly
        reduced also in the F1 offspring at the adult age. These results show that
        DEHP may have a number of adverse effects on oogenesis, especially when exposure
        occurs during early postnatal age, arising concerns about the exposure of
        human female infants and children to this compound.</AbstractText><CopyrightInformation>Copyright
        &#xa9; 2013 Wiley Periodicals, Inc.</CopyrightInformation></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Xi-Feng</ForeName><Initials>XF</Initials><AffiliationInfo><Affiliation>Key
        Laboratory of Animal Reproduction and Germplasm Enhancement in Universities
        of Shandong, Qingdao Agricultural University, Qingdao 266109, China.</Affiliation></AffiliationInfo></Author><Author
        ValidYN="Y"><LastName>Zhang</LastName><ForeName>Lian-Jun</ForeName><Initials>LJ</Initials></Author><Author
        ValidYN="Y"><LastName>Li</LastName><ForeName>Lan</ForeName><Initials>L</Initials></Author><Author
        ValidYN="Y"><LastName>Feng</LastName><ForeName>Yan-Ni</ForeName><Initials>YN</Initials></Author><Author
        ValidYN="Y"><LastName>Chen</LastName><ForeName>Bo</ForeName><Initials>B</Initials></Author><Author
        ValidYN="Y"><LastName>Ma</LastName><ForeName>Jin-Mei</ForeName><Initials>JM</Initials></Author><Author
        ValidYN="Y"><LastName>Huynh</LastName><ForeName>Evanna</ForeName><Initials>E</Initials></Author><Author
        ValidYN="Y"><LastName>Shi</LastName><ForeName>Qing-Hua</ForeName><Initials>QH</Initials></Author><Author
        ValidYN="Y"><LastName>De Felici</LastName><ForeName>Massimo</ForeName><Initials>M</Initials></Author><Author
        ValidYN="Y"><LastName>Shen</LastName><ForeName>Wei</ForeName><Initials>W</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research
        Support, Non-U.S. Gov''t</PublicationType></PublicationTypeList><ArticleDate
        DateType="Electronic"><Year>2013</Year><Month>04</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>United
        States</Country><MedlineTA>Environ Mol Mutagen</MedlineTA><NlmUniqueID>8800109</NlmUniqueID><ISSNLinking>0893-6692</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D052244">Endocrine Disruptors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D052244" MajorTopicYN="N">Endocrine Disruptors</DescriptorName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018613" MajorTopicYN="N">Microscopy, Confocal</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D009865" MajorTopicYN="N">Oocytes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000254" MajorTopicYN="N">growth
        &amp; development</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D009866" MajorTopicYN="N">Oogenesis</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D016133" MajorTopicYN="N">Polymerase Chain Reaction</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D008941" MajorTopicYN="N">Spindle Apparatus</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="received"><Year>2012</Year><Month>6</Month><Day>13</Day></PubMedPubDate><PubMedPubDate
        PubStatus="revised"><Year>2013</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate
        PubStatus="accepted"><Year>2013</Year><Month>3</Month><Day>7</Day></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2013</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="pubmed"><Year>2013</Year><Month>4</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2013</Year><Month>8</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">23625783</ArticleId><ArticleId IdType="doi">10.1002/em.21776</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation
        Status="MEDLINE" Owner="NLM"><PMID Version="1">11246142</PMID><DateCompleted><Year>2001</Year><Month>04</Month><Day>12</Day></DateCompleted><DateRevised><Year>2019</Year><Month>08</Month><Day>19</Day></DateRevised><Article
        PubModel="Print"><Journal><ISSN IssnType="Print">0300-483X</ISSN><JournalIssue
        CitedMedium="Print"><Volume>160</Volume><Issue>1-3</Issue><PubDate><Year>2001</Year><Month>Mar</Month><Day>07</Day></PubDate></JournalIssue><Title>Toxicology</Title><ISOAbbreviation>Toxicology</ISOAbbreviation></Journal><ArticleTitle>Weight-of-evidence
        versus strength-of-evidence in toxicologic hazard identification: Di(2-ethylhexyl)phthalate
        (DEHP).</ArticleTitle><Pagination><StartPage>219</StartPage><EndPage>226</EndPage><MedlinePgn>219-26</MedlinePgn></Pagination><Abstract><AbstractText>Toxicokinetic
        and mode of action data for DEHP reduce the concern for its potential carcinogenic
        hazard to human health. Chronic, high dose ingestion of DEHP and related peroxisome
        proliferators (PP) by mice and rats precipitate the following: activation
        of peroxisome proliferator activated receptor (PPARalpha) and its binding
        to peroxisome proliferator response elements (PPREs) within promoters of PP-responsive
        genes, peroxisome proliferation, increased microsomal fatty acid oxidation,
        increased hepatic hydrogen peroxide, hepatomegaly, hyperplasia and subsequent
        neoplasia. Neither peroxisome proliferation nor increased liver cancer occur
        in patients treated with pharmacologic doses of PP. Species differences in
        endogenous PPARalpha expression and differential activity of the peroxisome
        proliferator response element (PPRE) contribute to the failure of humans to
        respond in a manner qualitatively similar to that of rats or mice. Where it
        can be demonstrated that a mechanism for rodent tumor formation has no relevance
        for humans, then a substance which elicits a carcinogenic response in the
        test species via that mechanism should not be classified as anything other
        than an animal carcinogen. Systemic noncarcinogenic endpoints are available
        for definition of a DEHP reference dose. Considerable difficulty is encountered
        in the revision of promulgated regulations and in public risk communication
        when a material is no longer considered a carcinogenic hazard to humans.</AbstractText></Abstract><AuthorList
        CompleteYN="Y"><Author ValidYN="Y"><LastName>Willhite</LastName><ForeName>C
        C</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Department
        of Toxic Substances Control, State of California, 700 Heinz Street, Suite
        200, Berkeley, CA 94710, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType
        UI="D003160">Comparative Study</PublicationType><PublicationType UI="D016428">Journal
        Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Toxicology</MedlineTA><NlmUniqueID>0361055</NlmUniqueID><ISSNLinking>0300-483X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D002273">Carcinogens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D020025">Peroxisome Proliferators</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D018160">Receptors, Cytoplasmic and Nuclear</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance
        UI="D014157">Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>C42K0PH13C</RegistryNumber><NameOfSubstance
        UI="D004051">Diethylhexyl Phthalate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName
        UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D002273" MajorTopicYN="N">Carcinogens</DescriptorName><QualifierName UI="Q000145"
        MajorTopicYN="Y">classification</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004051" MajorTopicYN="N">Diethylhexyl Phthalate</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D004305" MajorTopicYN="N">Dose-Response Relationship, Drug</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D020025" MajorTopicYN="N">Peroxisome Proliferators</DescriptorName><QualifierName
        UI="Q000493" MajorTopicYN="Y">pharmacokinetics</QualifierName><QualifierName
        UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D020675" MajorTopicYN="N">Peroxisomes</DescriptorName><QualifierName UI="Q000187"
        MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D011640" MajorTopicYN="N">Public Policy</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D051381" MajorTopicYN="N">Rats</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D018160" MajorTopicYN="N">Receptors, Cytoplasmic and Nuclear</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName><QualifierName
        UI="Q000331" MajorTopicYN="N">legislation &amp; jurisprudence</QualifierName><QualifierName
        UI="Q000379" MajorTopicYN="Y">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D013045" MajorTopicYN="N">Species Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName><QualifierName
        UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378"
        MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName
        UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName
        UI="D014484" MajorTopicYN="N">United States Environmental Protection Agency</DescriptorName></MeshHeading></MeshHeadingList><NumberOfReferences>67</NumberOfReferences></MedlineCitation><PubmedData><History><PubMedPubDate
        PubStatus="pubmed"><Year>2001</Year><Month>3</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="medline"><Year>2001</Year><Month>4</Month><Day>17</Day><Hour>10</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate
        PubStatus="entrez"><Year>2001</Year><Month>3</Month><Day>14</Day><Hour>10</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId
        IdType="pubmed">11246142</ArticleId><ArticleId IdType="doi">10.1016/s0300-483x(00)00451-0</ArticleId><ArticleId
        IdType="pii">S0300483X00004510</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'
    headers:
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - X-RateLimit-Limit,X-RateLimit-Remaining
      Cache-Control:
      - private
      Connection:
      - Keep-Alive
      Content-Security-Policy:
      - upgrade-insecure-requests
      Content-Type:
      - text/xml; charset=UTF-8
      Date:
      - Thu, 05 Sep 2024 22:58:26 GMT
      Keep-Alive:
      - timeout=4, max=40
      NCBI-PHID:
      - D0BD9D8EE5AB4CE5000052EDB30E7CF6.1.1.m_3
      NCBI-SID:
      - 63CEAF308798EDA9_849ESID
      Referrer-Policy:
      - origin-when-cross-origin
      Server:
      - Finatra
      Set-Cookie:
      - ncbi_sid=63CEAF308798EDA9_849ESID; domain=.nih.gov; path=/; expires=Fri, 05
        Sep 2025 22:58:26 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains; preload
      Transfer-Encoding:
      - chunked
      X-RateLimit-Limit:
      - '10'
      X-RateLimit-Remaining:
      - '9'
      X-UA-Compatible:
      - IE=Edge
      X-XSS-Protection:
      - 1; mode=block
      content-encoding:
      - gzip
    status:
      code: 200
      message: OK
version: 1
